Related Research Reading The full Retatrutide research cluster: Retatrutide Research Guide, full mechanism, trial data, reconstitution, sourcing Retatrutide Statistics 2026, quick-facts data block, cohort numbers, trial registry Phase 3 TRIUMPH Update, current trial status across the TRIUMPH programme Dosing Protocol Reference, Phase 2 escalation schedule + reconstitution maths Side Effects (Phase 2 Data), full AE profile and discontinuation breakdown Retatrutide vs Tirzepatide, triple vs dual agonist research comparison Retatrutide vs Semaglutide, triple agonist vs GLP-1 single-receptor comparison Customer Reviews Crypto checkout was simpler than expected
Johansen, T.T
In the phase 2 trial, the most reported side effects were: Nausea (affecting around 40-50% of participants at higher doses) Vomiting Diarrhoea Constipation Decreased appetite (which is also the intended effect) Most of these were mild to moderate and occurred during the dose escalation phase
Although some improvements in pigmentation were observed in subgroups, results were mixed and highlighted the need for consistent use and further research Health+15CDEK Pharmacy+15ClinicalTrials.gov+15
Pathological alterations in gut microbiota induce the increased production of toxic metabolites and reduced production of beneficial compounds like short-chain fatty acids
